The Role of Patient Expectations in Traumatic Orthopedic Outcomes-TEFTOM EURASIA

Sponsor
AO Clinical Investigation and Publishing Documentation (Other)
Overall Status
Completed
CT.gov ID
NCT01134354
Collaborator
(none)
199
7
44.1
28.4
0.6

Study Details

Study Description

Brief Summary

Design:

Prediction trial, up to 10 sites in Asia and Europe

Goal:

To better understand the "success" or "failure" after orthopedic trauma surgery by developing a model that can be applied clinically as a user-friendly "baseline" questionnaire - capable of predicting "success" or "failure" based on a patient's pre-surgical expectations of their final outcome and to validate a novel outcomes measure (TOM).

Primary aim:

To assess the psychometric properties of predictive validity, internal consistency and reproducibility of the trauma expectation factor (TEF) in the Eurasian population.

Secondary aim:

To assess the psychometric properties of criterion validity, internal consistency,reproducibility, and sensitivity to change of the TOM in the Eurasian population.

Key questions related to patient and surgeon expectations:
  • How different, or similar, are patient and surgeon expectations?

  • Do expectations change over time?

  • Do patient expectations predict outcomes in validated measures use today?

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    199 participants
    Time Perspective:
    Prospective
    Official Title:
    The Role of Patient Expectations in Traumatic Orthopedic Outcomes TEFTOM: The Trauma Expectation Factor - Trauma Outcomes Measure TEFTOM EURASIA
    Study Start Date :
    Jun 1, 2010
    Actual Primary Completion Date :
    Feb 1, 2014
    Actual Study Completion Date :
    Feb 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    TEFTOM

    Patient outcome measure

    Outcome Measures

    Primary Outcome Measures

    1. Teftom Questionnaire [one year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Isolated ankle or distal tibia fracture

    • Scheduled for and undergoing one of the following surgeries for their fracture:

    • Open fracture and internal fixation (ORIF)

    • external fixation (EF)

    • EF followed by ORIF

    • 18 years of age or older

    • Understand and read country national language at elementary level

    • Able to understand the purpose of the clinical trial,

    • Able and willing to conduct all follow-up visits

    • Signed informed consent

    Exclusion Criteria:
    • Subject has previously undergone internal fixation surgery for this ankle/distal tibia fracture.

    • Subject has disease entity, or condition that precludes likelihood of bony union (e.g., metastatic cancer, metabolic bone disease).

    • Subject has severe dementia or other severe mental health problem that may preclude him/her from completing study questionnaires.

    • Subject is participating in other competing clinical research that may interfere with participation in this research.

    • Subject is unlikely to attend study related follow-up visits.

    • Subject has poly-trauma (more than one organ system compromised)

    • Subject has additional fracture(s) other than ankle fracture

    • Subject is a prisoner

    • Fracture occurred more than 28 days before surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Queen Mary Hospital Hong Kong China
    2 Shanghai Sixth People's Hospital Shanghai China 200233
    3 Universitätsklinikum Köln Köln Germany 50931
    4 HOSMAT Hospital Bangalore India 560025
    5 Hospital Universitari de Girona Doctor Josep Trueta Girona Spain 17007
    6 Kantonsspital Luzern Luzern Switzerland 6000
    7 Stadtspital Triemli Zürich Switzerland 8063

    Sponsors and Collaborators

    • AO Clinical Investigation and Publishing Documentation

    Investigators

    • Principal Investigator: Reto Babst, MD, Luzerner Kantonsspital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    AO Clinical Investigation and Publishing Documentation
    ClinicalTrials.gov Identifier:
    NCT01134354
    Other Study ID Numbers:
    • TEFTOM EURASIA
    First Posted:
    Jun 2, 2010
    Last Update Posted:
    Jun 19, 2014
    Last Verified:
    Jun 1, 2014
    Keywords provided by AO Clinical Investigation and Publishing Documentation
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 19, 2014